Tixagevimab/cilgavimab for Omicron SARS-CoV-2 infection in patients with haematologic diseases

Bone Marrow Transplant. 2023 Mar;58(3):340-342. doi: 10.1038/s41409-022-01894-1. Epub 2022 Dec 8.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19*
  • Hematologic Diseases*
  • Humans
  • SARS-CoV-2

Substances

  • tixagevimab
  • cilgavimab